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Background: Many common risk factors for cardiovascular disease (CVD) originate in childhood and adolescence.
There is a lack of literature examining variability within study populations, as well as a shortage of simultaneous
analyses of CVD risk factors operating in tandem.
Methods: We used data from Project HeartBeat!-a multi-cohort longitudinal growth study of children and adolescents
in the US - for assessing multiple profiles for lipids, blood pressure, and anthropometric measures. Principal component
functional curve analysis methods were used to summarize trajectories of multiple measurements. Subsequently less
favorable health (high risk) and more favorable (low risk) groups from both female and male cohorts were identified
and compared to US national norms.
Results: Compared to national norms, the high risk groups have increased waist circumference, body mass index, and
percent body fat as well as higher low-density lipoprotein cholesterol and triglyceride levels, and lower high-density
lipoprotein cholesterol. The risk profiles also exhibit patterns of convergence and divergence across the high and low
risk groups as a function of age.
Conclusions: These observations may have clinical and public health implications in identifying groups of children at
high risk of CVD for earlier interventions.
Keywords: Cardiovascular risk profiles, Health factors, Multivariable health factor profiles, Abdominal obesity,
Principal component functional curve, NHANES III
Background
Cardiovascular diseases (CVDs) often do not become
clinically manifest until adulthood. The cumulative ef-
fects of risk factors including abdominal obesity, ele-
vated body mass index (BMI) levels, dyslipidemia, and
hypertension originating in childhood may become clin-
ically manifested as coronary heart disease, heart failure,
and stroke [1–8]. Results from the Muscatine Study sug-
gest that previous values of lipid or blood pressure levels
for individuals at younger ages were strong predictors of
the values for individuals aged 20–39 years. Abdominal
obesity in particular often precedes other components of
the metabolic syndrome, and may play a role in the de-
velopment of other cardiovascular risk factors such as
hypertension [7, 9]. The cumulative life-course burden
of excessive body fat, as indicated by measures including
waist circumference, BMI, and percent body fat, begins
at an early age. These effects may transpire into cardio-
vascular events in adulthood, either through major risk
factors or, independent of them [9, 10].
While previous reports have described a broad picture
of the growth process on lipids, blood pressure, and an-
thropometry in adolescents and young adults across gen-
der and race subgroups [11–24], there are significant
questions that have not been directly addressed. First,
substantial variability exists in almost all of the lipid,
blood pressure, and anthropometric measures. Even
when the data are examined cross-sectionally, popula-
tion differences in cholesterol concentrations at a given
age were as great as 40–50 mg/dL [23]. Additionally,
temporal patterns differ significantly from individual to
individual within the same age-race subgroup.
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Typically, temporal patterns were depicted as smoothed
mean curves that were based on quadratic and cubic poly-
nomials for describing the change of lipids, blood pres-
sure, and anthropometry over the target age range [16].
Fig. 1 shows the growth trajectories of BMI using Project
HeartBeat! data, which were also used in the current ana-
lysis. The often-substantial variations across individuals in
the temporal patterns are not captured by a population-
averaged, model-based growth curve. It is possible that
subgroups of different risk strata exist within the popula-
tion. From a prevention point of view, these subgroups
need to be identified and carefully characterized.
A second question that has not been adequately addressed
in the prior literature concerning cardiovascular risk in
childhood and adolescence is the lack of analysis of multiple
profiles across lipids, blood pressure, and anthropometry.
Previous analysis has focused on single-variable trajectories
and has thus missed the opportunity to examine multiple
trajectories of cardiovascular outcomes from the same group
of individuals across an age span. For example, if the choles-
terol trajectory of a high-risk group suggests that cholesterol
tends to increase at an accelerated pace, then it would be
natural to ask whether or not the blood pressure of the same
group of individuals also increases over time.
The purpose of this study was to (1) analyze multiple pro-
files of lipids, blood pressure, and anthropometry using Pro-
ject HeartBeat! data, and (2) identify subgroups with different
cardiovascular risks. By understanding the overall risk pat-
terns that appear during early life, the findings in this study
could lead to early-life interventions for reducing or delaying
adversemetabolic changes and cardiovascular outcomes.
Methods
Data and measures
Project HeartBeat! is a population-based epidemiologic
study that examines early development of cardiovascular
risk factors in anthropometry, blood pressure, and lipids
as a growth process. Using intensive, longitudinal follow-
up assessments of children and adolescents, the study
collected data that offer a rich resource for determining
the cardiovascular profiles of individuals aged 8–18 and
their concurrent association with body size and compos-
ition. The study contained three separate cohorts that
were monitored for 4 years: cohort 1 of 8–12 years old;
cohort 2 of 11–15 years old; and cohort 3 of 14–18
years old, with a total sample size of N = 678 (49 % fe-
male, 20 % Black, total number of observations = 5500).
Data collection took place from October 1991 through
August 1995. Each participant was scheduled for examin-
ation three times each year. In the original study, the Uni-
versity of Texas Health Science Center at Houston and the
Baylor College IRBs approved data collection and the pro-
posed research. For the purposes of this analysis, only data
collected during the annual anniversary examinations, of
which the percentages of missing values were minimal,
were used. To facilitate comparison to previous results,
eight health measures used in previous studies were used in
this study. The measures include waist circumference
(WC, in cm), BMI, percent body fat (PBF, in %), low-
density lipoprotein cholesterol (LDL-C, in mg/dl),
high-density lipoprotein cholesterol (HDL-C, in mg/
dl), triglyceride (in mg/dl), and phase 4 diastolic and
systolic blood pressure (DBP and SBP, in mmHg).
Other potential cardiovascular risk variables such as
energy intake and physical activity have not been in-
cluded for comparability as well as technical reasons.
Inclusion of more variables, for example, tends to
lead to an increased number of only slightly different
cardiovascular profiles, making meanginful interpret-
ation of results challenging, Details of the study ra-
tionale, design, and data collection procedures have
been described elsewhere [24].
Statistical methods
Figure 1 shows the raw data trajectories for females for
one variable – BMI – in the three cohorts. For each
Fig. 1 Trajectories of the three cohorts for females in BMI (kg/m2), Project HeartBeat!
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cohort, we treated the repeated measurements (e.g.,
BMI) of an individual as constituting a functional curve
[25–27]. Therefore the multivariate approach implied
that each individual within an age cohort had a total of
8 functional curves to be simultaneously analyzed.
The analytic method comprised three steps: (1) func-
tional principal component (FPC) analysis for summariz-
ing the information contained in the functional curves
into a few numbers, called FPC scores [26, 27]; (2) mix-
ture modeling, or latent class analysis [28], for the FPC
values derived from the different variables to delineate
relatively homogeneous subgroups of individuals in
terms of their FPC values; and (3) projection of the FPCs
onto the original variable spaces to show the group-
based functional curves in their original scales because
FPC were combinations of the original variables and
were difficult to interpret. We used the Akaike Informa-
tion Criterion (AIC), a commonly used goodness-of-fit
index, in selecting the number of clusters (latent classes)
in step (2). The statistical testing of the difference be-
tween group-based functional curves, or trajectories,
was based on 95 % confidence bands of the mean group
trajectories.
In order to compare the group-based functional curves
with national norms, we also included gender-specific
population-level growth trajectories into our analysis
using NHANES III data. The NHANES III is a nationally
representative cross-sectional survey conducted during
the period of 1988 to 1994 [29, 30], which is contempor-
aneous with the HeartBeat! data collection phase. Except
for PBF, the NHANES III mean values reported in this
work were derived from raw data. In order to account
for the complex sampling design, proper sampling
weights for measurements collected from Mobile Exam-
ination Centers (MECs) were used in our derivation.
The mean values of PBF for some age groups were
adapted from a published reference [31]. Related na-
tional statistic for the measures used in this study and
related health guidelines can be found in other refer-
ences [32–35]. All analyses were performed in 2014–
2015.
Results
Based on the AIC, 2-cluster solutions were selected for
each age-gender cohort. The AIC values were close for
1-cluster and 2-cluster solutions for females in cohort
two, but the 2-cluster solution was ultimately favored.
Based on the overall lipid, blood pressure, and anthro-
pometry outcomes, we labeled the two clusters less fa-
vorable cardiovascular health group (LF-CHG) and more
favorable cardiovascular health group (MF-CHG). Note
that the MF- and LF-CHG were not defined by pre-
specified cut points; group membership was determined
through latent class analysis and the labels were assigned
based on inspection of the respective group trajectories.
Figure 2 shows two examples of the mean trajectories of
the MF- and LF-CHG and their respective 95 % confi-
dence bands. When two confidence bands on a specific
variable were completely separate and did not overlap,
statistical significance between the MF- and LF-CHG
was declared for the variable (p < .05). On the other and,
if any part of the group trajectories overlapped, then the
groups were deemed not statistically significant (p > .05).
Table 1 shows the descriptive statistics for the health
groups. Figures 3 (females) and 4 (males) show the aver-
aged functional curves of the LF-CHG and the MF-CHG
across the 8 designated measures. The functional curves
of the three cohorts are separately depicted. To facilitate
reading, the LF-CHG is indicated by a solid line and the
MF-CHG is indicated by a dashed line in each cohort.
The values in anthropometry, lipid level, and blood pres-
sure functional curves for the LF-CHG and MF-CHG
were contrasted and also compared with NHANES III
data for children aged 8–18 years old. Smoothed curves
for national data means were depicted as dotted lines in
Figs. 3 and 4. Specifically, the local polynomial regres-
sion fitting (LOESS) procedure [36], as implemented in
the function loess() in R with smoothing parameters set
at default values, was used for smoothing. Table 2 sum-
marizes the statistical testing results between the mean
trajectories of MF-CHG and the LF-CHG. As Figs. 3 and
4 visualize the results and Table 1 summarizes testing, in
the Result section we only highlight the most salient
findings.
Results for the three female cohorts
For the first cohort ( age 8–12 years) , 38 % (55/145) of
females belong to the LF-CHG, which is characterized
by an overall higher WC, higher BMI, higher PBF, higher
level of triglyceride, lower HDL-C, and higher LDL-C
(solid lines in Fig. 3 leftmost panels), as compared to the
MF-CHG (dashed lines). Waist circumference (WC) in
the MF-CHG female cohort one (~55 cm at age 8 and
~63 cm at age 12) is lower than the mean value obtained
from NHANES III (60.9 cm at age 8 and 72.9 cm at age
12) whereas WC in the LF-CHG is comparable (~62 cm
at age 8 and 70 cm at age 12). For BMI, the NHANES
III mean values for females 8–12 range from 17.7 kg/m2
(age 8) to 21.5 kg/m2 (age 12). The LF-CHG had a
higher BMI (~19 kg/m2 at age 8 and 22 kg/m2 at age
12). The separation of PBF between LF-CHG (~28 %)
and MF-CHG (~23 %) is also pronounced in this age co-
hort. Trajectories of LF-CHG and MF-CHG for HDL-C,
LDL-C, and triglycerides are separated, with the LDL-C
levels showing slightly declining trends.
Blood pressure levels in both the LF-CHG and MF-
CHG generally trend with the NHANES III averages but
the DBP levels are ~10 mmHg above. However, the
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trend lines for both DBP and SBP are not clearly sepa-
rated between the LF-CHG and MF-CHG.
For the second cohort (age 11–15 years), 19 % (16/85)
of females are identified as LF-CHG (solid lines in Fig. 3,
middle panels). Perhaps with the exception of DBP, the
two groups appear to be distinct across the various mea-
sures. Compared with the MF-CHG, the LF-CHG has
higher WC, BMI, PBF; higher triglyceride, higher LDL-
C, lower HDL-C, and higher SBP. BMI values of the
MF-CHG is lower than the NHANES III average, which
starts at 17.5 kg/m2 (age 11) and ends at 20 kg/m2 (age
15), while the BMI of the LF-CHG is ~2 to 3 kg/m2
above the NHANES III average. The HDL-C and LDL-C
levels of both the LF-CHG and MF-CHG are within an
acceptable range but the LF-CHG has an elevated level
of triglyceride (>110 mg/dl) almost throughout the en-
tire age range, suggesting that the LF-CHG is either at
the borderline-high (90–129 mg/dl) or high level
(130 mg/dl). The SBP between the two groups tends to
slightly diverge, with the LF-CHG trending higher, but
DBP levels are not well separated.
For the third cohort (age 14–18 years), the LF-CHG
constitutes approximately 35 % (27/77) of the cohort
(solid line in Fig. 3, rightmost panels). The most striking
Fig. 2 Examples of mean trajectories and 95 % confidence bands of the less favorable cardiovascular health group (LF-CHG, solid lines) and more
favorable cardiovascular health group (MF-CHG, dashed lines) for statistically non-significant different groups (left panel, SBP of 11-year old female
cohort) and statistically significant groups (right panel, SBP of 11-year old male cohort). For each group, a random sample (n = 10) of individual
trajectories are shown in shaded color in background
Table 1 Sample size and participant characteristics: Project HeartBeat!
8 year old cohort 11 year old cohort 14 year old cohort
MF-CHGa LF-CHGa MF-CHG LF-CHG MF-CHG LF-CHG
Males
n (%) 110 (72.8 %) 41 (27.2 %) 70 (72.2 %) 27 (27.8 %) 55 (77.5 %) 16 (22.5 %)
Race (n,%)
White 81 (75.8 %) 26 (24.3 %) 53 (72.6 %) 20 (27.4 %) 44 (73.3 %) 16 (26.7 %)
Black 22 (61.1 %) 14 (38.9 %) 12 (63.2 %) 7 (36.8 %) 4 (100 %) 0 (0 %)
Non-Black 7 (87.5 %) 1 (12.5 %) 5 (100 %) 0 (0 %) 7 (100 %) 0 (0 %)
Age (years)b 8.46 8.62 11.5 11.51 14.38 14.45
Females
n (%) 90 (62.1 %) 55 (37.9 %) 69 (81.2 %) 16 (18.8 %) 50 (64.9 %) 27 (35.1 %)
Race (n,%)
White 64 (62.1 %) 39 (37.9 %) 55 (82.1 %) 12 (17.9 %) 45 (71.4 %) 18 (28.6 %)
Black 22 (59.5 %) 15 (40.5 %) 11 (78.6 %) 3 (21.4 %) 4 (40.0 %) 6 (60.0 %)
Non-Black 4 (80.0 %) 1 (20.0 %) 3 (75.0 %) 1 (25 %) 1 (25 %) 3 (75.0 %)
Age (years) 8.54 8.51 11.5 11.54 14.44 14.48
aMF-CHG More favorable cardiovascular health group. LF-CHG Less favorable cardiovascular health group
bmean value
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Fig. 3 Trajectories of the less favorable cardiovascular health group (LF-CHG, solid lines) and more favorable cardiovascular health group (MF-CHG,
dashed lines) for the female cohorts. The national mean values derived from NHANES III are shown as dotted lines. The NHANES III curves have
been smoothed. Three age cohorts are shown separately in three column panels
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Fig. 4 Trajectories of the less favorable cardiovascular health group (LF-CHG, solid lines) and more favorable cardiovascular health group (MF-CHG,
dashed lines) for the male cohorts. The national mean values derived from NHANES III are shown as dotted lines. The NHANES III curves have been
smoothed. Three age cohorts are shown separately in three column pane
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feature is that the anthropometric measures—WC, BMI,
and PBF—all tend to be well separated for the LF-CHG
and MF-CHG while lipid measures—LDL-C, HDL-C,
and triglyceride—all tend to converge between the two
groups.
The levels of lipids in this cohort are not very well
separated between the LF-CHG and MF-CHG. For SBP,
the MF-CHG is approximately 5 mmHg lower than the
LF-CHG, of which the values are comparable to the
NHANES III mean values of this age range (105–
110 mmHg).
Results for the three male cohorts
For the first cohort of males, 27 % (41/151) of the
males are identified as belonging to the LF-CHG,
which exhibits higher BMI, WC, and PBF; higher tri-
glyceride (solid lines in Fig. 4, leftmost panels). The
PBF of this group (~27 %) is substantially higher than
the MF-CHG (~20 %). Interestingly, the lipid levels
and blood pressure levels of the LF-CHG and the
MF-CHG are not well separated and their values lie
within acceptable ranges.
For the second cohort of males, approximately 28 %
(27/97) belongs to the LF-CHG (solid lines in Fig. 4,
middle panels). Compared with the first cohort of males,
the most salient feature of this cohort is the divergence
of lipid measures and blood pressures. The LF-CHG has
higher WC, BMI, PBF; higher LDL-C, triglyceride, and
lower HDL-C; and higher SBP and DBP. Both the LF-
CHG and MF-CHG show a decline in LDL-C, as com-
pared to the relatively stable NHANES III trend
(~95 mg/dl) , although the LF-CHG and MF-CHG are
separated by a large gap of ~20 mg/dl.
For the third cohort of males, approximately 23 %
(16/71) is identified as belonging to the LF-CHG
(solid lines in Fig. 4, rightmost panels). Interestingly,
the anthropometric and lipid measures continue to
diverge and remain well apart for the LF-CHG and
the MF-CHG while the blood pressure measures show
convergence. The LF-CHG has substantially higher
WC (~85 cm), BMI (~26 kg/m2), PBF (~22 %), lower
HDL-C (~35 mg/dl), higher triglyceride levels (~140–
160 mg/dl), and higher LDL-C (~100 mg/dl) than the
MF-CHG. The elevated risk in this group seems to
lie in its high level of triglyceride (>130 mg/dl, or
high-level) as well as its consistent low level of HDL-
C at <40 mg/dl.
Discussion
Since the beginning of Project HeartBeat! in 1991,
obesity in the United States, especially in children
and adolescents, remains a prominent health concern
[37, 38]. Early prevention may be strengthened when
the relationship between obesity and cardiovascular
risk factors can be clearly delineated, as these factors
develop in childhood and adolescence [16, 23]. In this
study, principal component functional curve analysis
methods were used to summarize key features of tra-
jectories of multiple longitudinal measurements. The
principal components were then used to identify high
and low risk groups (respectively labeled LF-CHG and
MF-CHG) from both the male and female cohorts.
The high risk groups had greater waist circumference,
body mass index, and percent body fat as well as ele-
vated LDL cholesterol and triglyceride levels, and
lower HDL cholesterol levels. The risk profiles also
revealed patterns of convergence and divergence
across the high and low risk groups as a function of
age.
Some general trends can also be observed by examin-
ing the functional curves across the cohorts. These ob-
servations have clinical and public health practice
implications. For example, there are substantial age and
gender differences in the trajectories across the risk
groups MF-CGH and LF-CHG. Some measures such as
DBP for females were not discriminating and they may
not be useful to determine trajectories or characterize
cardiovascular risk groups. It is interesting to note that
for females, all lipid levels tend to show convergence be-
tween the LF-CHG and MF-CHG across the three age
cohorts, whereas those for males all tend to show strong
divergence. Our multi-variable analysis shows differences
Table 2 Result for statistical tests between LF-CHG and MF-CHG mean trajectories at the significance level of 0.05
WC BMI PBF HDL Triglyceride LDL SBP DBP
Females
8 year old cohort <.05 <.05 <.05 <.05 <.05
11 year old cohort <.05 <.05 <.05 <.05 <.05
14 year old cohort <.05 <.05
Males
8 year old cohort <.05 <.05 <.05
11 year old cohort <.05 <.05 <.05 <.05 <.05 <.05
14 year old cohort <.05 <.05 <.05 <.05 <.05 <.05
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in HDL-C as well as LDL-C for the two risk groups
begin at <3 mg/dl in cohort one and ends at >15 mg/dl
in cohort three. Differences in the males’ triglyceride
levels begin at <10 mg/dl at age 8 and end at >60 mg/dl
at age 17. The dynamic in these indicators may provide
clues to identifying important developmental periods for
intervention.
The findings from the current study can also be used
to inform future studies. For example, the identification
of the LF-CHG could be used to define an exposure
group in longitudinal studies for following up manifesta-
tions of heart disease or subclinical measures such as
carotid intima-media thickness. Previous research identi-
fied important measures that were predictive of cardio-
vascular problems later on in life. The Muscatine Study
[7, 9] suggested lipid and blood pressure levels at youn-
ger age were strong predictors of values later in life. The
Princeton Lipid Research Clinics Follow-up Study found
that 4.0 % of 771 children 6–19 years of age and
followed for 25 years had the metabolic syndrome.
Sixty-eight percent of those with the pediatric metabolic
syndrome had the metabolic syndrome as adults and
19.4 % with the pediatric metabolic syndrome had CVD
as adults, compared to 1.5 % for subjects without the
pediatric metabolic syndrome [39]. Findings from this
study point to early manifestation of cardiovascular risk
in younger age and provide quantitative information
about prevalence and trends. These findings could result
in earlier interventions for reducing or delaying adverse
metabolic changes and improving cardiovascular
outcomes.
The study has limitations. First the study is limited
by the lack of cohort data that span across all three
age groups. The analysis was limited to stratification
by gender and age-group. We have not further
evaluated race because of sample size concern. Add-
itionally, unlike NHANES III, the Project HeartBeat!
sample is not a representative national sample.
Finally, the study sample size is relatively small, espe-
cially for the LF-CHG. Because of this concern, re-
sults from this study may not be sufficiently robust to
generalize to larger populations. The study is descrip-
tive and the conclusion should not be viewed as
definitive.
Conclusions
Despite the aforementioned limitations, this study has
strengths in its concurrent examination of a profile of
cardiovascular risk factors including anthropometric,
lipid, and blood pressure measures in several cohorts
of boys and girls in their developmental stages. The
results are unique in its simultaneous depiction of
trajectories of the risk factors over time for a high-
risk and a low-risk group, as well as the national
norm, all by age group and gender. The findings
could be used as important reference for future stud-
ies of cardiovascular health in adolescents. Our
findings also suggest that male and female show ra-
ther distinct patterns in the trajectories, and lipid
measure such as HDL-C and LDL-C show strong pat-
terns of divergence in the risk groups while other
variables such as blood pressures appear to be less
discriminating.
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